Sastasundar Ventures (SASTASUNDR) | Financial Analysis & Statements
Sastasundar Ventures Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
2.8B
Gross Profit
211.4M
7.59%
Operating Income
-148.0M
-5.31%
Net Income
265.9M
9.54%
EPS (Diluted)
₹7.52
Balance Sheet Metrics
Total Assets
9.7B
Total Liabilities
1.1B
Shareholders Equity
8.6B
Debt to Equity
0.13
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Sastasundar Ventures Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 10.9B | 13.6B | 10.4B | 6.3B | 5.5B |
| Cost of Goods Sold | 10.2B | 12.4B | 9.7B | 5.9B | 4.9B |
| Gross Profit | 699.7M | 1.2B | 711.5M | 445.3M | 513.3M |
| Gross Margin % | 6.4% | 8.8% | 6.9% | 7.1% | 9.4% |
| Operating Expenses | |||||
| Research & Development | - | 0 | 177.0K | 0 | - |
| Selling, General & Administrative | 85.9M | 66.9M | 46.4M | 90.9M | 74.6M |
| Other Operating Expenses | 684.3M | 763.0M | 621.4M | 384.5M | 285.7M |
| Total Operating Expenses | 770.2M | 829.9M | 667.9M | 475.3M | 360.4M |
| Operating Income | -644.4M | -229.6M | -514.4M | -526.6M | -196.1M |
| Operating Margin % | -5.9% | -1.7% | -5.0% | -8.4% | -3.6% |
| Non-Operating Items | |||||
| Interest Income | 223.4M | 255.6M | 191.2M | 25.6M | 6.4M |
| Interest Expense | 2.2M | 10.1M | 8.7M | 16.2M | 9.4M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -2.0B | -305.0M | -1.2B | 11.1B | -163.7M |
| Income Tax | -701.2M | -363.5M | -227.8M | 2.4B | 7.3M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 22.0% | 0.0% |
| Net Income | -1.3B | 58.5M | -994.7M | 8.7B | -170.9M |
| Net Margin % | -12.3% | 0.4% | -9.6% | 137.4% | -3.1% |
| Key Metrics | |||||
| EBITDA | -349.8M | -724.9M | -1.1B | -500.3M | -152.3M |
| EPS (Basic) | ₹-28.66 | ₹2.79 | ₹-22.70 | ₹197.04 | ₹-3.27 |
| EPS (Diluted) | ₹-28.66 | ₹2.79 | ₹-22.70 | ₹197.04 | ₹-3.27 |
| Basic Shares Outstanding | 31810500 | 31810500 | 31810500 | 31810500 | 31810500 |
| Diluted Shares Outstanding | 31810500 | 31810500 | 31810500 | 31810500 | 31810500 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Sastasundar Ventures Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 124.2M | 336.1M | 317.2M | 130.1M | 120.4M |
| Short-term Investments | 3.9B | 329.3M | 1.8B | 2.0B | 97.0M |
| Accounts Receivable | 99.8M | 426.5M | 350.8M | 212.0M | 135.6M |
| Inventory | 1.1B | 1.2B | 1.8B | 1.1B | 771.8M |
| Other Current Assets | 360.9M | - | - | - | - |
| Total Current Assets | 5.8B | 2.8B | 4.9B | 3.6B | 1.4B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 99.8M | 140.9M | 198.2M | 571.6M | 263.4M |
| Goodwill | 723.7M | 723.4M | 723.9M | 724.0M | 1.1B |
| Intangible Assets | 792.0K | 556.0K | 992.0K | 1.2M | 4.3M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 6.7M | 61.1M | 52.2M | 249.2M | 771.8M |
| Total Non-Current Assets | 3.9B | 8.7B | 7.2B | 9.2B | 1.5B |
| Total Assets | 9.7B | 11.5B | 12.1B | 12.8B | 2.9B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 587.5M | 425.4M | 569.7M | 330.6M | 386.3M |
| Short-term Debt | 2.7M | 10.2M | 12.4M | 3.6M | 97.9M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 52.6M | - | - | - | - |
| Total Current Liabilities | 980.2M | 525.3M | 891.8M | 579.7M | 520.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 6.5M | 28.7M | 80.9M | 14.9M | 27.1M |
| Deferred Tax Liabilities | 39.7M | 676.4M | 925.3M | 1.1B | 3.0M |
| Other Non-Current Liabilities | 453.0K | 24.7M | 15.9M | 10.3M | 409.0K |
| Total Non-Current Liabilities | 118.2M | 975.3M | 1.2B | 1.3B | 114.2M |
| Total Liabilities | 1.1B | 1.5B | 2.1B | 1.8B | 634.3M |
| Equity | |||||
| Common Stock | 318.1M | 318.1M | 318.1M | 318.1M | 318.1M |
| Retained Earnings | 3.7B | 4.6B | 4.5B | 5.2B | -1.0B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 8.6B | 10.0B | 9.9B | 10.9B | 2.3B |
| Key Metrics | |||||
| Total Debt | 9.2M | 38.8M | 93.3M | 18.5M | 124.9M |
| Working Capital | 4.8B | 2.2B | 4.0B | 3.0B | 890.2M |
Balance Sheet Composition
Sastasundar Ventures Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -2.0B | -305.0M | -1.2B | 11.1B | -163.7M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 265.3M | 636.5M | -1.0B | -482.0M | 16.5M |
| Operating Cash Flow | -124.3M | 103.9M | -2.3B | 10.6B | -144.1M |
| Investing Activities | |||||
| Capital Expenditures | -100.7M | -136.0M | -161.9M | -46.8M | -9.4M |
| Acquisitions | 971.7M | - | - | - | - |
| Investment Purchases | -7.1B | -9.0B | -4.0B | -12.4B | -2.3B |
| Investment Sales | 6.1B | 8.6B | 5.3B | 14.6B | 2.5B |
| Investing Cash Flow | -132.1M | -558.6M | 1.1B | 2.2B | 199.6M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | 47.7M |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | - | - | - | -97.9M | 95.5M |
| Free Cash Flow | -276.7M | 239.3M | -1.3B | -2.1B | -314.9M |
| Net Change in Cash | -256.4M | -454.8M | -1.2B | 12.7B | 151.0M |
Cash Flow Trend
Sastasundar Ventures Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
33.04
Forward P/E
-15.28
Price to Book
1.26
Price to Sales
0.68
PEG Ratio
-0.32
Profitability Ratios
Profit Margin
2.04%
Operating Margin
0.30%
Return on Equity
-10.55%
Return on Assets
-9.36%
Financial Health
Current Ratio
2.13
Debt to Equity
0.59
Beta
0.37
Per Share Data
EPS (TTM)
₹8.19
Book Value per Share
₹214.21
Revenue per Share
₹401.47
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SASTASUNDR | 8.6B | 33.04 | 1.26 | -10.55% | 2.04% | 0.59 |
| Medplus Health | 108.8B | 52.45 | 5.89 | 8.64% | 3.17% | 64.69 |
| One Global Service | 11.0B | 21.06 | 10.22 | 25.75% | 14.00% | 0.03 |
| Trident Lifeline | 3.0B | 19.65 | 3.50 | 16.87% | 12.58% | 68.64 |
| Achyut Healthcare | 1.3B | 542.00 | 4.08 | 1.75% | 4.91% | 0.00 |
| Dipna Pharmachem | 228.2M | 10.09 | 0.35 | 4.24% | 1.92% | 23.42 |
Financial data is updated regularly. All figures are in the company's reporting currency.




